These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22480385)

  • 1. DNA fragments binding CTCF in vitro and in vivo are capable of blocking enhancer activity.
    Didych DA; Kotova ES; Akopov SB; Nikolaev LG; Sverdlov ED
    BMC Res Notes; 2012 Apr; 5():178. PubMed ID: 22480385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer-blocking activity is associated with hypersensitive site V sequences in the human growth hormone locus control region.
    Jin Y; Oomah K; Cattini PA
    DNA Cell Biol; 2011 Dec; 30(12):995-1005. PubMed ID: 21711161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of HSV-tk/GCV on hepatic specific damage driven by murine ALB promoter/enhancer.
    Zhang Y; Huang SZ; Zeng YT
    Yi Chuan Xue Bao; 2004 Oct; 31(10):1053-60. PubMed ID: 15552038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
    Liu XP; Li BJ; Zhang C
    Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chromatin insulator-like element in the herpes simplex virus type 1 latency-associated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities.
    Amelio AL; McAnany PK; Bloom DC
    J Virol; 2006 Mar; 80(5):2358-68. PubMed ID: 16474142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted gene therapy of nasopharyngeal cancer in vitro and in vivo by enhanced thymidine kinase expression driven by human TERT promoter and CMV enhancer.
    Shen CX; Wen Z; Qian YH; Mu SF; Guan XF
    J Exp Clin Cancer Res; 2010 Jul; 29(1):94. PubMed ID: 20626878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
    Eldholm V; Haugen A; Zienolddiny S
    Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suicide gene therapy using keratin 19 enhancer and promoter in malignant mesothelioma cells.
    Ishiwata N; Inase N; Fujie T; Tamaoka M; Yoshizawa Y
    Anticancer Res; 2003; 23(2B):1405-9. PubMed ID: 12820402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer sequences of the DF3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir.
    Manome Y; Abe M; Hagen MF; Fine HA; Kufe DW
    Cancer Res; 1994 Oct; 54(20):5408-13. PubMed ID: 7923173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TATA-dependent enhancer stimulation of promoter activity in mice is developmentally acquired.
    Majumder S; DePamphilis ML
    Mol Cell Biol; 1994 Jun; 14(6):4258-68. PubMed ID: 8196662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
    Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTCF-dependent chromatin boundary element between the latency-associated transcript and ICP0 promoters in the herpes simplex virus type 1 genome.
    Chen Q; Lin L; Smith S; Huang J; Berger SL; Zhou J
    J Virol; 2007 May; 81(10):5192-201. PubMed ID: 17267480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q; Zhang D; Wan M; Jin L
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a competitive PCR method for in vitro and in vivo quantification of herpes simplex virus thymidine kinase and neomycin resistance-expressing cells used in a clinical trial.
    Maddens S; Tiberghien P; Contassot E; Certoux JM; Chalmers D; Otto E; Hervé P; Ferrand C
    J Hematother Stem Cell Res; 2000 Apr; 9(2):225-36. PubMed ID: 10813536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypoxia responsive element regulated herpes simplex virus-thymidine kinase system enhances killing effect of gancyclovir on Ewing's sarcoma cell line under hypoxic condition].
    Si YJ; Guang LX; Yuan FH; Zhang KB
    Zhonghua Er Ke Za Zhi; 2006 Aug; 44(8):616-20. PubMed ID: 17083794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rasgrf1 imprinting is regulated by a CTCF-dependent methylation-sensitive enhancer blocker.
    Yoon B; Herman H; Hu B; Park YJ; Lindroth A; Bell A; West AG; Chang Y; Stablewski A; Piel JC; Loukinov DI; Lobanenkov VV; Soloway PD
    Mol Cell Biol; 2005 Dec; 25(24):11184-90. PubMed ID: 16314537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of cell and virus proteins with DNA sequences encompassing the promoter/regulatory and leader regions of the herpes simplex virus thymidine kinase gene.
    Papavassiliou AG; Silverstein SJ
    J Biol Chem; 1990 Jun; 265(16):9402-12. PubMed ID: 2160977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTCF-Mediated Enhancer-Promoter Interaction Is a Critical Regulator of Cell-to-Cell Variation of Gene Expression.
    Ren G; Jin W; Cui K; Rodrigez J; Hu G; Zhang Z; Larson DR; Zhao K
    Mol Cell; 2017 Sep; 67(6):1049-1058.e6. PubMed ID: 28938092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a large bent DNA domain and binding sites for serum response factor adjacent to the NFI repeat cluster and enhancer region in the major IE94 promoter from simian cytomegalovirus.
    Chang YN; Jeang KT; Chiou CJ; Chan YJ; Pizzorno M; Hayward GS
    J Virol; 1993 Jan; 67(1):516-29. PubMed ID: 8380090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drosophila CTCF is required for Fab-8 enhancer blocking activity in S2 cells.
    Ciavatta D; Rogers S; Magnuson T
    J Mol Biol; 2007 Oct; 373(2):233-9. PubMed ID: 17825318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.